Daniel Schurr

881 total citations
18 papers, 215 citations indexed

About

Daniel Schurr is a scholar working on Surgery, Genetics and Pharmacology. According to data from OpenAlex, Daniel Schurr has authored 18 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 4 papers in Genetics and 3 papers in Pharmacology. Recurrent topics in Daniel Schurr's work include Lipoproteins and Cardiovascular Health (9 papers), Pharmacology and Obesity Treatment (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Daniel Schurr is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Pharmacology and Obesity Treatment (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Daniel Schurr collaborates with scholars based in Israel, United States and South Africa. Daniel Schurr's co-authors include Eran Leitersdorf, Shlomit Gorelik, Ron Kohen, Joseph Kanner, Avishalom Pomeranz, Alfred Drukker, Deborah Rund, Soamnauth Misir, A. David Marais and Michael Melino and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Daniel Schurr

17 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Schurr Israel 8 130 60 36 26 26 18 215
Vicente Pascual Fuster Spain 7 87 0.7× 53 0.9× 51 1.4× 13 0.5× 7 0.3× 36 252
Adrielle H Houweling Canada 7 170 1.3× 27 0.5× 45 1.3× 25 1.0× 7 0.3× 8 256
Ågot Lia Amundsen Norway 8 223 1.7× 90 1.5× 50 1.4× 74 2.8× 23 0.9× 9 335
G Urbinati Italy 8 105 0.8× 75 1.3× 69 1.9× 28 1.1× 12 0.5× 16 346
Cumhur Kılınç Türkiye 8 89 0.7× 129 2.1× 45 1.3× 93 3.6× 23 0.9× 14 329
R. De Simone Italy 7 54 0.4× 35 0.6× 58 1.6× 10 0.4× 47 1.8× 11 196
Verónica Escurriol Spain 7 160 1.2× 64 1.1× 26 0.7× 73 2.8× 65 2.5× 9 341
N. Attia Tunisia 7 71 0.5× 83 1.4× 36 1.0× 39 1.5× 7 0.3× 14 172
Longina Kłosiewicz−Latoszek Poland 9 144 1.1× 78 1.3× 66 1.8× 24 0.9× 9 0.3× 57 301
Ana Piñar-Gutiérrez Spain 6 77 0.6× 25 0.4× 20 0.6× 32 1.2× 14 0.5× 19 226

Countries citing papers authored by Daniel Schurr

Since Specialization
Citations

This map shows the geographic impact of Daniel Schurr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Schurr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Schurr more than expected).

Fields of papers citing papers by Daniel Schurr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Schurr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Schurr. The network helps show where Daniel Schurr may publish in the future.

Co-authorship network of co-authors of Daniel Schurr

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Schurr. A scholar is included among the top collaborators of Daniel Schurr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Schurr. Daniel Schurr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Golomb, Mordechai, Rafael Bitzur, Ronen R. Leker, et al.. (2025). Missing in action: the genetic mysteries of extremely low HDL cholesterol. Frontiers in Cardiovascular Medicine. 12. 1553259–1553259.
2.
Winther, Michael D., Shoshi Shpitzen, Daniel Schurr, et al.. (2019). In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in MTTP explain only part of LDL variability in an FH family. Journal of Lipid Research. 60(10). 1733–1740. 2 indexed citations
3.
Durst, Ronen, Shoshi Shpitzen, Daniel Schurr, et al.. (2016). Molecular genetics of familial hypercholesterolemia in Israel–revisited. Atherosclerosis. 257. 55–63. 17 indexed citations
4.
Schurr, Daniel, et al.. (2014). [Statins and muscle pain].. PubMed. 153(7). 423–7, 431. 1 indexed citations
5.
Durst, Ronen, Shoshi Shpitzen, Dan Schwarzfuchs, et al.. (2012). INSULIN RECEPTOR SUBSTRATE 1 GENE VARIATION MODIFIES INSULIN RESISTANCE RESPONSE TO VARIOUS TYPES OF DIETARY STRATEGIES: RESULTS FROM THE DIRECT INTERVENTION TRIAL. Journal of the American College of Cardiology. 59(13). E1664–E1664. 1 indexed citations
6.
Gorelik, Shlomit, Joseph Kanner, Daniel Schurr, & Ron Kohen. (2012). A rational approach to prevent postprandial modification of LDL by dietary polyphenols. Journal of Functional Foods. 5(1). 163–169. 41 indexed citations
7.
Cohen, Hofit, Chen Stein‐Zamir, Yael Lebenthal, et al.. (2010). Israeli guidelines for the management of hypercholesterolemia in children and adolescents. Report of the pediatric association expert group. e-SPEN the European e-Journal of Clinical Nutrition and Metabolism. 5(3). e132–e143. 2 indexed citations
8.
Stein, Evan A., A. David Marais, Tamás Szamosi, et al.. (2009). Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia. The Journal of Pediatrics. 156(2). 231–236.e3. 52 indexed citations
9.
Stein, Evan A., David Marais, Tamás Szamosi, et al.. (2009). Efficacy and Safety of Colesevelam HCl in Pediatric Patients with Heterozygous Familial Hypercholesterolemia. Journal of clinical lipidology. 3(3). 220–220. 1 indexed citations
10.
Schurr, Daniel, et al.. (2009). Long‐term plasma exchange for severe refractory hypertriglyceridemia: A decade of experience demonstrates safety and efficacy. Journal of Clinical Apheresis. 24(6). 254–258. 25 indexed citations
11.
Stein, Evan A., David Marais, Tamás Szamosi, et al.. (2008). Abstract 3699: Efficacy and Safety of Colesevelam HCl in Pediatric Patients with Heterozygous Familial Hypercholesterolemia. Circulation. 118(suppl_18). 1 indexed citations
12.
Diamond, Gary, Yehuda Senecky, Daniel Schurr, et al.. (2003). Pre-placement screening in international adoption.. PubMed. 5(11). 763–6. 10 indexed citations
13.
Durst, Ronen, et al.. (2002). One year experience with a low density lipoprotein apheresis system.. PubMed. 4(9). 677–80. 3 indexed citations
14.
Schurr, Daniel, et al.. (1995). High-dose fluvastatin and bezafibratecombination treatment for heterozygous familial hypercholesterolemia. The American Journal of Cardiology. 76(1-2). 76A–79A. 24 indexed citations
15.
Pomeranz, Avishalom, et al.. (1985). Acute renal failure in a burn patient: the advantages of continuous peritoneal dialysis. Burns. 11(5). 367–370. 7 indexed citations
16.
Schurr, Daniel, Avishalom Pomeranz, & Alfred Drukker. (1984). Dialysis-Induced Hypoxemia. ˜The œNephron journals/Nephron journals. 37(2). 105–107. 6 indexed citations
17.
Pomeranz, Avishalom, et al.. (1984). Chyloperitoneum: A Rare Complication of Peritoneal Dialysis. Peritoneal Dialysis International. 4(1). 35–37. 15 indexed citations
18.
Schurr, Daniel, et al.. (1983). Unusual Presentation of Vitamin A Intoxication. Journal of Pediatric Gastroenterology and Nutrition. 2(4). 705–707. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vicente Pascual Fuster Breakdown of academic impact, for papers by Adrielle H Houweling Breakdown of academic impact, for papers by Ågot Lia Amundsen Breakdown of academic impact, for papers by G Urbinati Breakdown of academic impact, for papers by Cumhur Kılınç Breakdown of academic impact, for papers by R. De Simone Breakdown of academic impact, for papers by Verónica Escurriol Breakdown of academic impact, for papers by N. Attia Breakdown of academic impact, for papers by Longina Kłosiewicz−Latoszek Breakdown of academic impact, for papers by Ana Piñar-Gutiérrez
Rankless by CCL
2026